Xeris Biopharma Holdings, Inc. Common Stock XERS
$6.18
+0.49%
at last close
Financials (TTM)
- Revenue
- $314.85 million
- Net Income
- $12.01 million
- Net Margin
- 3.81%
- Return on Equity
- 92.29%
- Debt-to-Equity
- 17.00
- P/E Ratio
- 88.29
- Price / Book
- 81.60
- Price / Sales
- 3.37
Over the trailing twelve months, Xeris Biopharma Holdings, Inc. Common Stock generated revenue of $314.85 million and net income of $12.01 million, a net margin of 3.81%.
At the last closing price of $6.18, XERS trades at 88.29 times trailing earnings and 3.37 times sales, with a market capitalization of $1.06 billion.
Key Stats
- Last Close
- $6.18
- Market Cap
- $1.06 billion
- 52-Week Range
- $4.25 – $10.08
- Average Volume
- 1.62 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.